Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer.

Authors
Publication date
Publisher
'Springer Fachmedien Wiesbaden GmbH'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Warwick Research Archives Portal Repository

    redirect
    oaioai:wrap.warwick.ac.uk:32369
    Last time updated on 03/04/2012